This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Guangzhou Inno-Enmai Biomedical Technology Co., Ltd, Other. Active years: 2012-2026.
Company Filing History:
2 out of 3,346 
1 out of 1 
1 out of 834,453 Years Active: 2012-2026
Title: Yingfang Liu: Innovator in Protein Research
Introduction
Yingfang Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of protein research, particularly in relation to diseases associated with the IFP35 family of proteins. With a total of 4 patents, his work has implications for both treatment and diagnosis of various disorders.
Latest Patents
Yingfang Liu's latest patents include innovative methods and compositions for treating and preventing diseases linked to abnormal levels of the IFP35 family of proteins. His first patent focuses on methods for diagnosing and monitoring diseases associated with high levels of IFP35 and NMI proteins. The second patent reveals the three-dimensional crystal structure of the amino terminal portion of the influenza virus polymerase PA subunit. This invention provides valuable insights for drug screening and design, showcasing the potential for new therapeutic approaches.
Career Highlights
Throughout his career, Yingfang Liu has worked with esteemed institutions, including the Chinese Academy of Sciences. His research has not only advanced scientific understanding but also paved the way for practical applications in medicine.
Collaborations
Yingfang Liu has collaborated with notable colleagues such as Jie Zhou and Huanhuan Liang. These partnerships have contributed to the success of his research endeavors and the development of his patents.
Conclusion
Yingfang Liu's innovative work in protein research exemplifies the impact of scientific inquiry on healthcare. His patents reflect a commitment to addressing critical health challenges through advanced methodologies.